Literature DB >> 19092369

An integrated approach to the diagnosis and treatment of anxiety within the practice of cardiology.

David Janeway1.   

Abstract

Coronary heart disease (CHD) is the leading cause of death and disability in the United States and in highly industrialized countries. Many modifiable psychosocial risk factors have been identified and can affect the course of cardiac illness. These include the negative emotional states of depression, anxiety, stress, anger/hostility, and social isolation. Anxiety has been found to increase the risk of developing CHD in healthy subjects and can lead to worsening of existing CHD. There is much overlap and confusion throughout the research literature between what authors define as anxiety, stress, Type A behavioral pattern, and anger/hostility.There is a need for better screening within the practice of cardiology for these psychosocial risk factors to ensure better integration of mental health services. Established screening tools such as the Beck Anxiety Inventory, Patient Health Questionnaire-9, Zung Self-Rating Anxiety Scale, and the Hamilton Anxiety Scale are described and compared with the newer Screening Tool for Psychologic Distress as part of the initial work-up of every cardiac patient. Recommendations are made using the author's Anxiety Treatment Algorithm regarding when to refer to a mental health professional along with how to reduce stigma and provide more integrated care. The diagnosis and treatment of anxiety disorders is reviewed, with attention to selective serotonin reuptake inhibitors, benzodiazepines, cognitive-behavioral therapy, stress reduction, and behavioral medicine group programs. These group programs are recommended because they help to overcome social isolation and counsel patients on how to adapt to a healthy lifestyle. Better clinical outcome research is needed that specifically addresses the question of whether the treatment of anxiety and anxiety disorders can affect the course of cardiac illness.

Entities:  

Mesh:

Year:  2009        PMID: 19092369     DOI: 10.1097/CRD.0b013e3181867fe3

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  7 in total

1.  Measures of anxiety, amygdala volumes, and hippocampal scopolamine phMRI response in elderly female rhesus macaques.

Authors:  Gwendolen E Haley; Acacia McGuire; Daphnee Berteau-Pavy; Alison Weiss; Roshni Patel; Ilhem Messaoudi; Henryk F Urbanski; Jacob Raber
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

2.  Gender as a determinant of responses to a self-screening questionnaire on anxiety and depression by patients with coronary artery disease.

Authors:  Colleen M Norris; Amanda Ljubsa; Kathleen M Hegadoren
Journal:  Gend Med       Date:  2009-09

3.  Anxiety symptoms among Chinese nurses and the associated factors: a cross sectional study.

Authors:  Yu-Qin Gao; Bo-Chen Pan; Wei Sun; Hui Wu; Jia-Na Wang; Lie Wang
Journal:  BMC Psychiatry       Date:  2012-09-14       Impact factor: 3.630

4.  Psychiatric disorders and cardiac anxiety in exercising and sedentary coronary artery disease patients: a case-control study.

Authors:  A Sardinha; C G S Araújo; A E Nardi
Journal:  Braz J Med Biol Res       Date:  2012-08-23       Impact factor: 2.590

Review 5.  Assessment of patient-reported symptoms of anxiety.

Authors:  Matthias Rose; Janine Devine
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

Review 6.  Psychological and Psychopharmacological Interventions in Psychocardiology.

Authors:  Kai G Kahl; Britta Stapel; Christoph U Correll
Journal:  Front Psychiatry       Date:  2022-03-16       Impact factor: 4.157

7.  Screening for anxiety disorders in patients with coronary artery disease.

Authors:  Adomas Bunevicius; Margarita Staniute; Julija Brozaitiene; Victor J M Pop; Julius Neverauskas; Robertas Bunevicius
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.